Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009.

MLA

Xiang, Yu-Tao, et al. “Clozapine Use in Schizophrenia: Findings of the Research on Asia Psychotropic Prescription (REAP) Studies from 2001 to 2009.” The Australian and New Zealand Journal of Psychiatry, vol. 45, no. 11, Nov. 2011, pp. 968–75. EBSCOhost, https://doi.org/10.3109/00048674.2011.607426.

APA

Xiang, Y.-T., Wang, C.-Y., Si, T.-M., Lee, E. H. M., He, Y.-L., Ungvari, G. S., Chiu, H. F. K., Shinfuku, N., Yang, S.-Y., Chong, M.-Y., Kua, E.-H., Fujii, S., Sim, K., Yong, M. K. H., Trivedi, J. K., Chung, E.-K., Udomratn, P., Chee, K.-Y., Sartorius, N., … Tan, C.-H. (2011). Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009. The Australian and New Zealand Journal of Psychiatry, 45(11), 968–975. https://doi.org/10.3109/00048674.2011.607426

Chicago

Xiang, Yu-Tao, Chuan-Yue Wang, Tian-Mei Si, Edwin H M Lee, Yan-Ling He, Gabor S Ungvari, Helen F K Chiu, et al. 2011. “Clozapine Use in Schizophrenia: Findings of the Research on Asia Psychotropic Prescription (REAP) Studies from 2001 to 2009.” The Australian and New Zealand Journal of Psychiatry 45 (11): 968–75. doi:10.3109/00048674.2011.607426.